Singapore - engelsk - HSA (Health Sciences Authority)

v 2 u healthcare pte. ltd. - physical medicine - indications pain management: - symptomatic relief and management of chronic, intractable pain. - management of pain associated with post- traumatic or postoperative conditions; indications muscle stimulation: - relaxation of muscle spasms - prevention or retardation of disuse atrophy - increasing local blood circulation - muscle re-education - immediate post-surgical stimulation of calf muscles to prevent venous thrombosis - maintaining or increasing range of motion

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dantrolene sodium hemiheptahydrate, quantity: 50 mg - capsule - excipient ingredients: sodium lauryl sulfate; maize starch; lactose monohydrate; titanium dioxide; sunset yellow fcf; gelatin; iron oxide yellow; iron oxide red; magnesium stearate; purified talc; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy. if improvement occurs, it will ordinarily occur within the dosage titration schedule (see dosage and administration), as manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrium. occasionally, subtle but meaningful improvements in spasticity may occur with dantrium therapy. in such instances informat

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dantrolene sodium hemiheptahydrate, quantity: 25 mg - capsule - excipient ingredients: titanium dioxide; sunset yellow fcf; purified talc; gelatin; iron oxide red; magnesium stearate; maize starch; sodium lauryl sulfate; lactose monohydrate; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - dantrium is indicated in controlling the manifestations of clinical spasticity resulting from serious chronic disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. it is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. there is no evidence that patients with contractures will benefit. dantrium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders or electroconvulsive therapy. if improvement occurs, it will ordinarily occur within the dosage titration schedule (see dosage and administration), as manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrium. occasionally, subtle but meaningful improvements in spasticity may occur with dantrium therapy. in such instances inf

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

cantley medical services pty ltd - 47517 - arm rehabilitation system - the pablo equipment is for the rehabilitation of the hand, arm and shoulder and provides the possibnility of actively training all parts of the upper limbs

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

rothcorp australia pty ltd atf iw rothall family trust no. 2 trading as merits australasia and the rehabilitation centre - 11634 - exerciser, respiratory - these devices helps in active and passive exercises for elderly and disabled people.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

md solutions australasia pty ltd -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

global protect pty ltd - 58270 - vertical vibration exerciser, stationary - the wbv-3000 applies the theory of whole body vibration to stimulate the neuromuscular system to improve muscle strength, joint proprioception, bone density, muscle length and blood circulation. functional benefits include improved gait; better balance to reduce the risk of falls; improved coordination, flexibility and power for everyday activities or sport; and reduced pain. the wbv-3000 has a vibrating platform that oscillates side to side. this produces an even, low impact movement which alternates the rise and fall of each side of the platform, producing a gentle tilting movement on each side of the body. this motion is similar to the action of raising one leg as the other lowers during walking. the tilting action of the platform is delivered by an electric motor integrated within the device base. the frequency and amplitude of the vibration can be altered depending on the intended outcome. the higher the amplitude the more the muscles, tendons, joints and nervous system must respond to the mechanical mov